☰

Mansi Parasramka, Ph.D. - Publications

Affiliations: 
2010 Nutrition and Food Science Wayne State University, Detroit, MI, United States 
Area:
Nutrition, Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Parasramka MA, Gupta SV. Erratum to "Synergistic Effect of Garcinol and Curcumin on Antiproliferative and Apoptotic Activity in Pancreatic Cancer Cells". Journal of Oncology. 2019: 7469284. PMID 31379944 DOI: 10.1155/2019/7469284  0.626
2017 Parasramka M, Yan IK, Wang X, Nguyen P, Matsuda A, Maji S, Foye C, Asmann Y, Patel T. BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma. Molecular Cancer. 16: 22. PMID 28122578 DOI: 10.1186/S12943-017-0587-X  0.336
2017 Matsuda A, Parasramka M, Yan I, Catherine F, Patel T. Therapeutic Efficacy of Anti-Programmed Cell Death Protein 1 Antibody and Effect of Vitamin D Supplementation in Hepatocellular Carcinoma Associated with B-Catenin Activation and Over Expression of CMET Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)33945-8  0.335
2017 Leibovich B, Serie D, Ho T, Cheville J, Joseph R, Parasramka M, Thompson RH, Parker A, Eckel-Passow J. Pd52-11 A Molecular Scoring Algorithm To Predict Survival In Metastatic Renal Cell Carcinoma The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2199  0.322
2016 Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW. Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death. European Urology Focus. 2: 608-615. PMID 28723492 DOI: 10.1016/J.Euf.2016.03.008  0.355
2016 Ho TH, Serie DJ, Parasramka M, Cheville JC, Bot BM, Tan W, Wang L, Joseph RW, Hilton T, Leibovich BC, Parker AS, Eckel-Passow JE. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 27993815 DOI: 10.1093/Annonc/Mdw652  0.377
2016 Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. European Urology. PMID 27899233 DOI: 10.1016/J.Eururo.2016.11.018  0.451
2016 Parasramka MA, Patel T. Long non-coding RNA regulation of liver cancer stem cell self-renewal offers new therapeutic targeting opportunities. Stem Cell Investigation. 3: 1. PMID 27358893 DOI: 10.3978/j.issn.2306-9759.2016.01.01  0.316
2015 Joseph RW, Kapur P, Serie DJ, Parasramka M, Ho TH, Cheville JC, Frenkel E, Parker AS, Brugarolas J. Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression. The Journal of Urology. PMID 26300218 DOI: 10.1016/J.Juro.2015.07.113  0.467
2015 Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Parasramka M, Cheville JC, Wu KJ, Frenkel E, Rakheja D, Stefanius K, Brugarolas J, Parker AS. Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma. Urologic Oncology. 33: 23.e9-14. PMID 25465300 DOI: 10.1016/J.Urolonc.2014.10.014  0.418
2014 Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. European Urology. 66: 929-35. PMID 24388441 DOI: 10.1016/J.Eururo.2013.12.017  0.455
2014 Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer. 120: 1059-67. PMID 24382589 DOI: 10.1002/Cncr.28521  0.414
2014 Parasramka M, Proia DA, Joseph RW. Preclinical activity of the heat shock protein 90 inhibitor ganetespib in clear cell renal cell carcinoma. Journal of Clinical Oncology. 32: 478-478. DOI: 10.1200/Jco.2014.32.4_Suppl.478  0.438
2014 Joseph RW, Kapur P, Serie D, Cheville JC, Eckel-Passow J, Parasramka M, Ho TH, Kwon ED, Thompson RH, Brugarolas J, Parker AS. Association of loss of BAP1 expression in cell renal cell carcinomas with PDL1 expression. Journal of Clinical Oncology. 32: 4530-4530. DOI: 10.1200/Jco.2014.32.15_Suppl.4530  0.451
2014 Ho TH, Kapur P, Joseph RW, Serie D, Eckel-Passow J, Parasramka M, Cheville JC, Brugarolas J, Parker AS. Loss of BAP1 and PBRM1 expression in non-clear cell renal cell carcinomas compared to clear cell renal cell carcinomas. Journal of Clinical Oncology. 32: 4529-4529. DOI: 10.1200/Jco.2014.32.15_Suppl.4529  0.449
2014 Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel EP, Rakheja D, Brugarolas J, Parker A. Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma (Cancer DOI: 10.1002/cncr.28521) Cancer. 120: 1752-1753. DOI: 10.1002/Cncr.28615  0.48
2013 Joseph RW, Serie D, Hilton TW, Parasramka M, Eckel-Passow J, Cheville J, Leibovich BC, Parker AS. Association of topoisomerase II expression and cancer-specific death in patients with surgically resected clear cell renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 446. PMID 28136928 DOI: 10.1200/Jco.2013.31.15_Suppl.E15539  0.503
2013 Joseph RW, Parasramka M, Eckel-Passow JE, Serie D, Wu K, Jiang L, Kalari K, Thompson RH, Huu Ho T, Castle EP, Cheville J, Kwon ED, Thompson EA, Parker A. Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma. Cancer Immunology Research. 1: 378-85. PMID 24778130 DOI: 10.1158/2326-6066.Cir-13-0042  0.38
2013 Joseph RW, Parasramka M, Serie D, Eckel-Passow J, Thompson EA, Lohse CM, Ho TH, Castle EP, Thompson RH, Leibovich BC, Cheville J, Parker AS. Validation of an inverse association between programmed death ligand 1 (PDL1) and genes in the vascular endothelial growth factor (VEGF) pathway in primary clear cell renal cell (ccRCC). Journal of Clinical Oncology. 31: 4567-4567. DOI: 10.1200/Jco.2013.31.15_Suppl.4567  0.357
2013 Joseph RW, Serie D, Hilton T, Parasramka M, Eckel-Passow J, Cheville J, Leibovich BC, Parker AS. Abstract 15: Association of topoisomerase II expression and cancer-specific death in patients with surgically-resected clear cell renal cell carcinoma. Cancer Research. 73: 15-15. DOI: 10.1158/1538-7445.Am2013-15  0.489
2012 Parasramka MA, Gupta SV. Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. Journal of Oncology. 2012: 709739. PMID 22685460 DOI: 10.1155/2012/709739  0.64
2011 Parasramka MA, Gupta SV. Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells. Nutrition and Cancer. 63: 456-65. PMID 21462088 DOI: 10.1080/01635581.2011.535962  0.647
Show low-probability matches.